Darwin Global Management reports 5.11% voting rights stake in Genmab
GMAB•Darwin Global Management disclosed voting rights equivalent to 3,188,361 Genmab shares, or 5.11%, as of Sept. 28, 2026.
1. Voting rights disclosure
Darwin Global Management disclosed it controls voting rights in Genmab equivalent to 3,188,361 shares, or 5.11%. The holding includes shares and ADRs held through funds and portfolios managed by Darwin, as of Sept. 28, 2026.
